- Home
- MRX vs TVTX Comparison
MRX vs TVTX Comparison
Compare MRX & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRX
- TVTX
- Stock Information
- Founded
- MRX 2005
- TVTX 2008
- Country
- MRX United Kingdom
- TVTX United States
- Employees
- MRX N/A
- TVTX N/A
- Industry
- MRX
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MRX
- TVTX Health Care
- Exchange
- MRX NYSE
- TVTX Nasdaq
- Market Cap
- MRX 1.6B
- TVTX 1.3B
- IPO Year
- MRX 2024
- TVTX N/A
- Fundamental
- Price
- MRX $28.91
- TVTX $17.86
- Analyst Decision
- MRX Strong Buy
- TVTX Buy
- Analyst Count
- MRX 7
- TVTX 13
- Target Price
- MRX $30.71
- TVTX $23.46
- AVG Volume (30 Days)
- MRX 694.8K
- TVTX 1.4M
- Earning Date
- MRX 11-07-2024
- TVTX 10-31-2024
- Dividend Yield
- MRX 0.48%
- TVTX N/A
- EPS Growth
- MRX 2.80
- TVTX N/A
- EPS
- MRX 2.51
- TVTX N/A
- Revenue
- MRX $1,539,450,000.00
- TVTX $203,447,000.00
- Revenue This Year
- MRX N/A
- TVTX $62.45
- Revenue Next Year
- MRX $5.45
- TVTX $59.30
- P/E Ratio
- MRX $11.52
- TVTX N/A
- Revenue Growth
- MRX N/A
- TVTX 57.08
- 52 Week Low
- MRX $18.13
- TVTX $5.12
- 52 Week High
- MRX $29.26
- TVTX $20.33
- Technical
- Relative Strength Index (RSI)
- MRX N/A
- TVTX 52.82
- Support Level
- MRX N/A
- TVTX $16.86
- Resistance Level
- MRX N/A
- TVTX $19.51
- Average True Range (ATR)
- MRX 0.00
- TVTX 1.13
- MACD
- MRX 0.00
- TVTX -0.23
- Stochastic Oscillator
- MRX 0.00
- TVTX 28.82
About MRX MAREX GROUP PLC
Marex Group PLC is a company that offers a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. It provides critical services to the clients by connecting them to global exchanges and providing a range of execution and hedging services across a range of its asset and products. They operate in a large and fragmented market with significant infrastructure requirements and regulatory and technological complexity, resulting in high barriers to entry.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.